Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

Presentation TCT 2024

TCT 1497: Complex PCI in a High-Risk Woman With NSTEMI and SCAI B Cardiogenic Shock

Presenter: Daniel Lira-Lozano

October 30, 2024

Presentation TCT 2024

TCT 1551: Left Main Bifurcation PCI in a Patient With NSTEMI and Cardiogenic Shock on ECMO

Presenter: Prakriti Gaba

October 30, 2024

Presentation TCT 2024

TCT 805: Differences in Presentation, Management and Outcomes Between STEMI and NSTEMI Cardiogenic Shock

Presenter: Allan Lin

October 29, 2024

Presentation TCT 2024

TCT 172: Usefulness of FFR-CT to Exclude Hemodynamically Significant Lesions in High-Risk NSTE-ACS

Presenter: Georgios Tzimas

October 28, 2024

News Daily News

MI Care Varies Across Asian Subgroups in the US

Yael L. Maxwell

September 19, 2024

News Conference News ESC 2024

Complete Revascularization Better for Older STEMI Patients: Meta-analysis

Todd Neale

September 04, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

L.A. McKeown

August 15, 2024

News Conference News SCCT 2024

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Todd Neale

July 25, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Conference News SCAI 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

L.A. McKeown

May 10, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

Presentation Fellows 2024

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Binita Shah

April 12, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Advertisement

December 2024 Dispatch for the CV Team

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

TCT 1497: Complex PCI in a High-Risk Woman With NSTEMI and SCAI B Cardiogenic Shock

TCT 1551: Left Main Bifurcation PCI in a Patient With NSTEMI and Cardiogenic Shock on ECMO

TCT 805: Differences in Presentation, Management and Outcomes Between STEMI and NSTEMI Cardiogenic Shock

TCT 172: Usefulness of FFR-CT to Exclude Hemodynamically Significant Lesions in High-Risk NSTE-ACS

MI Care Varies Across Asian Subgroups in the US

Complete Revascularization Better for Older STEMI Patients: Meta-analysis

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

State-of-the-Art in NSTE-ACS: Management Strategies

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content